Official release from AI companies

OpenAI has launched the new 'Monday' voice feature for ChatGPT, accessible to all users. To use it, update the app and select 'Monday' from the voice picker in voice mode.

OpenAI has introduced a new voice feature in ChatGPT, enhancing user interaction with a more natural conversational experience.

OpenAI has introduced a new voice feature in ChatGPT, allowing users to access it by opening voice mode and selecting the voice picker in the top right corner.

Google DeepMind announces the rollout of Gemini 2.5 Pro, an experimental AI model, to all Gemini users. The team emphasizes their commitment to making this advanced model widely accessible as they continue to enhance its capabilities.

Google DeepMind highlights the launch of Gemini 2.5 Pro, showcasing its advanced reasoning, coding capabilities, and multimodal strengths, including a 1M token long context, in a detailed breakdown by product leads.

Google DeepMind introduces FirePlace, a framework showcased at #CVPR2025 that allows Multimodal LLMs to generate realistic and geometrically valid object placements in complex 3D scenes, enhancing 3D scene building.

OpenAI has launched native image generation in ChatGPT through model 4o, emphasizing a shift towards nuanced policy that balances user creativity with the prevention of real-world harm.

The latest update to GPT-4o in ChatGPT enhances its ability to follow complex instructions, solve technical problems, and boosts creativity while reducing emoji usage.

OpenAI has updated GPT-4o in ChatGPT, enhancing its ability to follow complex instructions, solve technical problems, and boost creativity, while reducing emoji usage. The update is available to paid users now, with free users to follow soon.

Anthropic has released the second research report from their Anthropic Economic Index, revealing a slight increase in Claude 3.7 Sonnet's usage for coding, education, science, and healthcare applications.

Google DeepMind introduces TxGemma, an advanced model built on Gemma technology, designed to understand and predict properties of small molecules and proteins, aiding in faster identification of clinical trial targets and cost reduction.

Google DeepMind introduces TxGemma, an advanced AI model designed to streamline drug development by predicting properties of small molecules and proteins, potentially accelerating research and reducing costs.